Revvity, Inc. Share Price & Technical Analysis

RVTY · $96.95 (+1.65%)

Healthcare / Diagnostics & Research

AI Score 48 · Weak

$96.95

+1.65%

Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents, assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectiou

Price chart

Seasonality

May has 3 positive and 2 negative years (last 5 years shown)

12% return in May, -3% avg return in past 3 year May month.

7% return in 2026, -8% avg return in past 3 years.

Swipe sideways to see all months →

JanFebMarAprMayJunJulAugSepOctNovDecYr
2612%-6%-9%-2%12%7%
2512%-11%-6%-11%-5%8%-9%4%-2%7%13%-6%-6%
24-2%1%-3%-2%6%-4%20%-3%5%-7%-3%-4%4%
23-3%-11%8%-1%-12%2%4%-6%-6%-25%6%23%-21%
22-14%4%-3%-17%2%-5%8%-20%-10%10%3%-1%-43%

Monthly return % by calendar month · historical pattern, not a forecast

AI snapshotScore 48/100

Weak · Emerging · Uptrend

Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents, assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. The company also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, chemagic, Chitas, CNGnome, DELFIA, DELFIA Xpress, EONIS, EUROArray , EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, GSP, Haoyuan, IDS Immunodiagnosticsystems, IDS-i10, IDS-i10T, IDS-i20, IDS-iSYS, iLab, iQ, LifeCycle, LimsLink, Migele, NeoBase, NeoLSD, NEXTFLEX, Panthera Puncher, PreNAT II, Prime, RONIA, SimplicityChrom, Specimen Gate, Superflex, Symbio, T-SPOT, Vanadis, ViaCord, VICTOR2, and WholePanel brand names, as well as under the Accell, AlphaLISA, AlphaPlex, AlphaScreen, Alpha SureFire, AssayMate, BIOCHIPs, BioLegend, Bioo Scientific, BioQule, Brilliant Violet, Ce3D, CellCarrier, Cellaca, Celigo, Cellometer, cell::explorer, Cell-Vive, Chalice, ChemDraw, CHOSOURCE, Dharmacon, and DharmaFECT brand names. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

Full AI Q&A, portfolio tracking, and live alerts in the app.

Key metrics

Market cap

$11.08B

P/E ratio

47.63

52W high

$118.3

52W low

$81.22

Volume

7,80,348

Beta

1.05

Related stocks in Healthcare

Frequently asked questions

What is Revvity, Inc. share price today?
Revvity, Inc. (RVTY) last traded around $96.95 on StockPro. Prices refresh every few minutes during market hours.
What technical signals does RVTY have?
StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for RVTY. Download the app for real-time alerts.
How can I analyze Revvity, Inc. stock?
Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.

Explore more on StockPro